Effect of potassium channel modulators in mouse forced swimming test
- 1 April 1999
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 126 (7), 1653-1659
- https://doi.org/10.1038/sj.bjp.0702467
Abstract
1. The effect of intracerebroventricular (i.c.v.) administration of different potassium channel blockers (tetraethylammonium, apamin, charybdotoxin, gliquidone), potassium channel openers (pinacidil, minoxidil, cromakalim) and aODN to mKv1.1 on immobility time was evaluated in the mouse forced swimming test, an animal model of depression. 2. Tetraethylammonium (TEA; 5 microg per mouse i.c.v.), apamin (3 ng per mouse i.c.v.), charybdotoxin (1 microg per mouse i.c.v.) and gliquidone (6 microg per mouse i.c.v.) administered 20 min before the test produced anti-immobility comparable to that induced by the tricyclic antidepressants amitriptyline (15 mg kg(-1) s.c.) and imipramine (30 mg kg(-1) s.c.). 3. By contrast pinacidil (10-20 microg per mouse i.c.v.), minoxidil (10-20 microg per mouse i.c.v.) and cromakalim (20-30 microg per mouse i.c.v.) increased immobility time when administered in the same experimental conditions. 4. Repeated administration of an antisense oligonucleotide (aODN) to the mKv1.1 gene (1 and 3 nmol per single i.c.v. injection) produced a dose-dependent increase in immobility time of mice 72 h after the last injection. At day 7, the increasing effect produced by aODN disappeared. A degenerate mKv1.1 oligonucleotide (dODN), used as control, did not produce any effect in comparison with saline- and vector-treated mice. 5. At the highest effective dose, potassium channels modulators and the mKv1.1 aODN did not impair motor coordination, as revealed by the rota rod test, nor did they modify spontaneous motility as revealed by the Animex apparatus. 6. These results suggest that modulation of potassium channels plays an important role in the regulation of immobility time in the mouse forced swimming test.Keywords
This publication has 36 references indexed in Scilit:
- Effect of fluoxetine on a neuronal, voltage‐dependent potassium channel (Kv1.1)British Journal of Pharmacology, 1997
- The effect of the potassium channel activator, cromakalim, on antidepressant drugs in the forced swimming test in miceFundamental & Clinical Pharmacology, 1996
- Additive effects of glyburide and antidepressants in the forced swimming test: Evidence for the involvement of potassium channel blockadePharmacology Biochemistry and Behavior, 1996
- Detection of serotonergic and noradrenergic antidepressants in the rat forced swimming test: the effects of water depthBehavioural Brain Research, 1995
- MOLECULAR AND FUNCTIONAL DIVERSITY OF K+ CHANNELSClinical and Experimental Pharmacology and Physiology, 1995
- Cloning and expression of cDNA and genomic clones encoding three delayed rectifier potassium channels in rat brainNeuron, 1990
- A Family of Three Mouse Potassium Channel Genes with Intronless Coding RegionsScience, 1990
- Potassium channel toxinsPharmacology & Therapeutics, 1990
- The pharmacology of potassium channels and their therapeutic potentialTrends in Pharmacological Sciences, 1988
- Charybdotoxin, a protein inhibitor of single Ca2+-activated K+ channels from mammalian skeletal muscleNature, 1985